3-57198276-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM5PP3_StrongPP5
The NM_003865.3(HESX1):c.479G>A(p.Arg160His) variant causes a missense change. The variant allele was found at a frequency of 0.000031 in 1,612,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R160C) has been classified as Pathogenic.
Frequency
Consequence
NM_003865.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HESX1 | NM_003865.3 | c.479G>A | p.Arg160His | missense_variant | 4/4 | ENST00000295934.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HESX1 | ENST00000295934.8 | c.479G>A | p.Arg160His | missense_variant | 4/4 | 1 | NM_003865.3 | P1 | |
HESX1 | ENST00000647958.1 | c.479G>A | p.Arg160His | missense_variant | 7/7 | P1 | |||
HESX1 | ENST00000473921.2 | c.377G>A | p.Arg126His | missense_variant | 3/3 | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.0000263 AC: 4AN: 151974Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000797 AC: 2AN: 250942Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135760
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1460858Hom.: 0 Cov.: 30 AF XY: 0.0000344 AC XY: 25AN XY: 726724
GnomAD4 genome ? AF: 0.0000263 AC: 4AN: 151974Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74228
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | May 23, 2018 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 07, 2022 | Seen in the heterozygous state in a patient with panhypopituitarism and inherited from an unaffected father; patient did not have an identifiable second variant in HESX1 but also had a variant in the PROP1 gene (Blum et al., 2018); Published functional studies demonstrate that R160H significantly impaired the role of HESX1 as a transcriptional repressor (Fang et al., 2016); This variant is associated with the following publications: (PMID: 25500790, 30487145, 22145475, 27000987, 30266296, 32621723) - |
Septo-optic dysplasia sequence;C2750027:Growth hormone deficiency with pituitary anomalies Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Jan 06, 2024 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 160 of the HESX1 protein (p.Arg160His). This variant is present in population databases (rs766234350, gnomAD 0.005%). This missense change has been observed in individual(s) with clinical features of septo-optic dysplasia (PMID: 22145475, 25500790, 27000987, 30266296). ClinVar contains an entry for this variant (Variation ID: 985575). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects HESX1 function (PMID: 27000987). This variant disrupts the p.Arg160 amino acid residue in HESX1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9620767, 19093031). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at